glp-1 and cardiovascular benefits Complementary Yet Distinct Roles of Receptor Agonists SGLT2 Inhibitors in Risk Reduction Does GLP-1 Help Lower Cholesterol?

Weight Management May support ongoing weight-management efforts for eligible patients when prescribed as part of a personalized treatment plan

In terms of the primary outcome of reduction in A1C from baseline, although the 3-mg oral semaglutide group did not demonstrate superiority to sitagliptin 100 mg at 26 weeks, the 7-mg and 14-mg dosage groups did demonstrate statistically significant reductions in A1C from baseline when compared with sitagliptin

Consider setting reminders if you're not feeling naturally thirsty

As summarized in Table S1, the level of evidence is still low, derived mainly from in vitro studies, animal models, and small patient cohorts, with only limited data from RCT available

For weight management, GLP-1 medicines can help people feel fuller, reduce appetite and support weight loss when used alongside diet, physical activity and ongoing clinical support